Reuters reports the Hyderabad drugmaker expanded its generic semaglutide lineup to cover a supply-chain problem with its original Obeda brand.
Recap by typeshit. Full story at Reuters on MSN.
General exercise advice aimed at GLP-1 users, shared on Facebook with no study or expert named in the material available.
Gilead takes global rights to the Shanghai biotech's program, led by HCXT-2001, an oral peptide that could compete with injected IBD drugs.
A Facebook promo for a podcast episode on the ripple effects of GLP-1 consumers across businesses. Few details beyond the pitch.
10:49
xitsnemox posts a short check-in from week 14 on oral Wegovy, two weeks after stepping up to the 25mg tablet. A personal account, not medical advice.
Started in 20-month-old female mice, the drug matched many benefits of calorie restriction and beat it on spatial memory and glucose control, the authors report.
A basic rundown of Mounjaro as a type 2 diabetes medication that can also aid weight loss, plus the downsides to know.
Loading…